Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
DiscussionThe present study was approved and conducted as an initiative study of the Japanese Association for Acute Medicine. If non-inferiority is identified, the society will pursue an application for the national health insurance coverage of levetiracetam for SE via a public knowledge-based application.Trial registrationJapan Registry of Clinical TrialsjRCTs031190160. Registered on December 13, 2019
Source: Trials - Category: Research Source Type: clinical trials
More News: Arrhythmia | Diazepam | Emergency Medicine | Health Insurance | Insurance | Japan Health | Phenytoin | Research | Study | Valium